Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials


A Double-blind, Randomized, Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal BPL-003 (5-Methoxy-N,N-dimethyltryptamine Benzoate) in Healthy Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05347849

Organisation Name: Beckley Psytech Limited

Overal Status: Recruiting

Start Date: February 14, 2022

Last Update: April 26, 2022

Lead Sponsor: Beckley Psytech Limited

Brief Summary: The study will evaluate safety, tolerability and PK profile of BPL-003 in healthy subjects

Conditions:
  • Pharmacokinetics in Healthy Adults


Total execution time in seconds: 0.16309905052185